Literature DB >> 10639404

Requirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice.

K L Buchanan1, H A Doyle.   

Abstract

The importance of cell-mediated immunity (CMI) and CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans is well documented and is exemplified by the high susceptibility to progressive infection with this pathogen of AIDS patients with reduced CD4(+) T-cell numbers. Although much has been learned about the role of CMI in the clearance of C. neoformans from the lungs and other internal organs, less is known about the protective mechanisms in the brain, the organ most frequently involved with a fatal outcome of cryptococcosis. We hypothesized that host resistance mechanisms against C. neoformans in the central nervous system (CNS) were similar to those outside the CNS (i.e., gamma interferon [IFN-gamma], CD4(+) T cells, and others). To test this hypothesis, we used a murine model of cryptococcal meningitis whereby cryptococci are introduced directly into the CNS. In experiments where mice were immunized to mount an anticryptococcal CMI response, our results indicate that immunization induced protective mechanisms that could be detected in the CNS by inhibition of the growth of viable yeast cells. Flow cytometric analyses of leukocytes in brain and spinal cord homogenates revealed that T lymphocytes, macrophages, and neutrophils accumulated in C. neoformans-infected brains of immune mice. In vivo depletion of CD4(+) T cells, but not CD8(+) T cells, resulted in significantly reduced leukocyte accumulation in the brains of immune mice. Furthermore, depletion of CD4(+) T cells or neutralization of IFN-gamma exacerbated CNS infection in immune mice, suggesting a critical role for CMI mechanisms in acquired protection in the CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639404      PMCID: PMC97163          DOI: 10.1128/IAI.68.2.456-462.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice.

Authors:  K A Hoag; N E Street; G B Huffnagle; M F Lipscomb
Journal:  Am J Respir Cell Mol Biol       Date:  1995-10       Impact factor: 6.914

2.  Biomolecular events involved in anticryptococcal resistance in the brain.

Authors:  E Blasi; R Barluzzi; R Mazzolla; L Pitzurra; M Puliti; S Saleppico; F Bistoni
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

3.  Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.

Authors:  I E Flesch; G Schwamberger; S H Kaufmann
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

4.  Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice.

Authors:  T S Lim; J W Murphy; L K Cauley
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

5.  Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line.

Authors:  E Blasi; R Barluzzi; R Mazzolla; B Tancini; S Saleppico; M Puliti; L Pitzurra; F Bistoni
Journal:  J Neuroimmunol       Date:  1995-04       Impact factor: 3.478

6.  T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

7.  T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-gamma and its protective effect against cryptococcal infection.

Authors:  K Kawakami; S Kohno; J Kadota; M Tohyama; K Teruya; N Kudeken; A Saito; K Hara
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

8.  Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans.

Authors:  C H Mody; M F Lipscomb; N E Street; G B Toews
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

9.  Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

10.  Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells.

Authors:  J O Hill; A G Harmsen
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.

Authors:  Karen L Wozniak; Camaron R Hole; Junko Yano; Paul L Fidel; Floyd L Wormley
Journal:  Microbiology (Reading)       Date:  2014-04-23       Impact factor: 2.777

3.  Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.

Authors:  Enrique Calvo; F Javier Pastor; M Mar Rodríguez; Isabel Pujol; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

Review 4.  Role of microglia in fungal infections of the central nervous system.

Authors:  George W Koutsouras; Raddy L Ramos; Luis R Martinez
Journal:  Virulence       Date:  2016-11-18       Impact factor: 5.882

5.  Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation.

Authors:  Ziba Jalali; Lucky Ng; Nina Singh; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2006-07

6.  Distinct compartmentalization of CD4+ T-cell effector function versus proliferative capacity during pulmonary cryptococcosis.

Authors:  Dennis M Lindell; Thomas A Moore; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 7.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation.

Authors:  Vanessa Espinosa; Amariliz Rivera
Journal:  Cytokine       Date:  2011-11-30       Impact factor: 3.861

8.  Increased susceptibility against Cryptococcus neoformans of lupus mouse models (pristane-induction and FcGRIIb deficiency) is associated with activated macrophage, regardless of genetic background.

Authors:  Saowapha Surawut; Jiradej Makjaroen; Arthid Thim-Uam; Jutamas Wongphoom; Tanapat Palaga; Prapaporn Pisitkun; Ariya Chindamporn; Asada Leelahavanichkul
Journal:  J Microbiol       Date:  2018-11-19       Impact factor: 3.422

9.  Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice.

Authors:  Erin E McClelland; Donald L Granger; Wayne K Potts
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Sailatha Ravi; Sandra Macias; Mattie L Young; Michal A Olszewski; Chad Steele; Floyd L Wormley
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.